Rocket Pharma stocks cardiac gene therapies through $53 million acquisition of Renovacor

Gene therapy developer Rocket Pharmaceuticals is on track to gain FDA approval for its pioneering program, but it’s also interested in preserving its pipeline inventory. The company agreed to Acquisition of Renovacora biotechnology working to develop a gene therapy for a form of hereditary heart failure. According to financial terms announced Tuesday, the all-share transaction … Read more

Cigna Extends Coverage of Brainsway’s Brain Stimulator to Treat OCD

Obsessive-compulsive disorder (OCD) It was Rank by World Health Organization As one of the 10 most debilitating medical conditions in terms of income loss and reduced quality of life. The condition is complex and presents differently in each patient, and many of them are drug-resistant. These challenges make treating OCD difficult. Many patients with this … Read more